Folated Synperonic-Cholesteryl Hemisuccinate Polymeric Micelles for the Targeted Delivery of Docetaxel in Melanoma

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Treatment groups</td><td align="center">Tumor weight (g)</td><td align="center">Means for survival time</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Normal saline</td><td align="center">10.92 ± 4.06</td><td align="center">13 ± 2.074</td></tr><tr><td align="left">DTX-loaded FA-PF127-Chol micelles</td><td align="center">0.78 ± 0.19</td><td align="center">&gt;17.4</td></tr><tr><td align="left">DTX-loaded PF127-Chol micelles</td><td align="center">2.21 ± 0.38</td><td align="center">17.2 ± 2.01</td></tr><tr><td align="left">Taxotere</td><td align="center">2.85 ± 1.45</td><td align="center">17.4 ± 4.47</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Effect of different treatment on tumor weight and means for survival time.

BioMed Research International

tab5

Table 5

Table 5: Folated Synperonic-Cholesteryl Hemisuccinate Polymeric Micelles for the Targeted Delivery of Docetaxel in Melanoma 